A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer

Summary

This study is a randomized, double-blind, multicenter, phase Ⅲ clinical study to compare the clinical efficacy and safety of Docetaxel for Injection (Albumin Bound) in combination with best supportive care versus placebo in combination with best supportive care in participants with pancreatic cancer who have received gemcitabine-containing and fluorouracil-containing regimens.

Timeline

Start

2024-08-12

Primary completion

2026-04-14

Completion

2026-11-21

Drugs

Indications